Nyse american to commence delisting proceedings against timber pharmaceuticals, inc. (tmbr)

New york--(business wire)--nyse american llc (“nyse american” or the “exchange”) announced today that the staff of nyse regulation has determined to commence proceedings to delist the common stock of timber pharmaceuticals, inc. (the “company”) — ticker symbol tmbr — from nyse american. nyse regulation has determined that the company is no longer suitable for listing and will commence delisting proceedings pursuant to section 1003(c)(iii) of the nyse american company guide in light of the compa.
TMBR Ratings Summary
TMBR Quant Ranking